141 related articles for article (PubMed ID: 2475710)
1. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
Persson B; Wysocki M; Andersson OK
J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
[TBL] [Abstract][Full Text] [Related]
2. Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine.
Krusell LR; Jespersen LT; Schmitz A; Thomsen K; Pedersen OL
Hypertension; 1987 Dec; 10(6):577-81. PubMed ID: 2447016
[TBL] [Abstract][Full Text] [Related]
3. Renal and hemodynamic effects of isradipine in essential hypertension.
Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M
Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension.
Staessen J; Lijnen P; Fagard R; Hespel P; Tan WP; Devos P; Amery A
J Cardiovasc Pharmacol; 1989 Feb; 13(2):271-6. PubMed ID: 2468957
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
Nelson EB; Pool JL; Taylor AA
Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
[TBL] [Abstract][Full Text] [Related]
7. Central hemodynamics and brachial artery compliance during therapy with isradipine, a new calcium antagonist.
Andersson OK; Persson B; Widgren BR; Wysocki M
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S87-9. PubMed ID: 1695312
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
Kirch W; Burger KJ; Weidinger G; Welzel D
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism.
Francischetti EA; Barroso I; da Silva A; Fagundes VG
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847
[TBL] [Abstract][Full Text] [Related]
10. Treatment of essential hypertension with PN 200-110 (isradipine).
Hamilton BP
Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
[TBL] [Abstract][Full Text] [Related]
13. Effects of isradipine on hypertension and renal hemodynamics.
Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846
[TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
Welzel D; Burger KJ; Weidinger G
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of isradipine on blood pressure and renal function.
Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K
Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650
[TBL] [Abstract][Full Text] [Related]
16. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.
Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA
Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765
[TBL] [Abstract][Full Text] [Related]
17. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of the new calcium channel blocking drug isradipine.
Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
[TBL] [Abstract][Full Text] [Related]
19. The long-term effect of isradipine in pindolol-treated patients.
Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
Christensen HR; Kampmann JP; Simonsen K
J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
